576 results on '"Fulp, William"'
Search Results
2. Diagnostic Resolution of Cancer Screening Abnormalities at Community Health Centers
3. Surgeon Bias in the Management of Positive Sentinel Lymph Nodes
4. Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?
5. Intrinsic radiosensitivity, genomic-based radiation dose and patterns of failure of penile cancer in response to adjuvant radiation therapy
6. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases
7. The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis
8. The Impact of Socioeconomic Deprivation on Clinical Outcomes for Pancreatic Adenocarcinoma at a High-volume Cancer Center: A Retrospective Cohort Analysis
9. Tumour radiosensitivity is associated with immune activation in solid tumours
10. A first-in-human germline-targeting HIV nanoparticle vaccine induced broad and publicly targeted helper T cell responses
11. Supplementary Table S1 from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
12. Data from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
13. Supplementary Figure S3 from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
14. Supplementary Figure Legends from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
15. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study
16. Variability of CD4+ Cell Counts in HIV-1–Uninfected Volunteers Who Are Eligible for a Phase I HIV Vaccine Study
17. Data from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
18. Supplementary Tables 1 - 2 from Validation of a Radiosensitivity Molecular Signature in Breast Cancer
19. Supplementary Figure 1 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
20. Supplementary Table 2 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
21. Supplementary Methods from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
22. Data from Racial Differences in the Incidence and Clearance of Human Papilloma Virus (HPV): The HPV in Men (HIM) Study
23. Supplementary Data from Combination of Farnesyltransferase and Akt Inhibitors Is Synergistic in Breast Cancer Cells and Causes Significant Breast Tumor Regression in ErbB2 Transgenic Mice
24. Supplementary Table 1 from Racial Differences in the Incidence and Clearance of Human Papilloma Virus (HPV): The HPV in Men (HIM) Study
25. Supplementary Table 1 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
26. Supplementary Table 3 from BAD Phosphorylation Determines Ovarian Cancer Chemosensitivity and Patient Survival
27. Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
28. Clinical prognostic factors and outcomes of essential thrombocythemia when transformed to myelodysplastic syndromes and acute myeloid leukemia
29. Human Papillomavirus (HPV) L1 Serum Antibodies and the Risk of Subsequent Oral HPV Acquisition in Men: The HIM Study
30. Human immunoglobulin gene allelic variation impacts germline-targeting vaccine priming
31. Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer
32. Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection
33. Acceptance and adherence to chemoprevention among women at increased risk of breast cancer
34. Vaccination induces HIV broadly neutralizing antibody precursors in humans
35. Human Papillomavirus Virus (HPV) Genotype- and Age-Specific Analyses of External Genital Lesions Among Men in the HPV Infection in Men (HIM) Study
36. Radiation Therapy is Associated with Improved Outcomes in Merkel Cell Carcinoma
37. Florida Initiative for Quality Cancer Care: Improvements in Breast Cancer Quality Indicators During a 3-Year Interval
38. Senescence-associated-gene signature identifies genes linked to age, prognosis, and progression of human gliomas
39. Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study
40. Antitumor Efficacy of the Anti-Interleukin-6 (IL-6) Antibody Siltuximab in Mouse Xenograft Models of Lung Cancer
41. The Role of Monogamy and Duration of Heterosexual Relationships in Human Papillomavirus Transmission
42. TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients
43. 'Secure' Log-Linear and Logistic Regression Analysis of Distributed Databases
44. Outcomes of a Clinical Pathway for Borderline Resectable Pancreatic Cancer
45. Phase I trial of combination of FOLFIRI and pasireotide, a somatostatin analogue, in advanced gastrointestinal malignancies
46. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma
47. Consistent Condom Use Reduces the Genital Human Papillomavirus Burden Among High-Risk Men: The HPV Infection in Men Study
48. Country‐specific HPV‐related genital disease among men residing in Brazil, Mexico and The United States: The HIM study
49. Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer
50. A Meta-analysis of Randomized Clinical Trials of Chemoradiation Therapy in Locally Advanced Pancreatic Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.